Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia [PDF]
Chronic neutrophilic leukemia (CNL) relates to mutational CSF3R activation with membrane proximal CSF3R mutations such as T618I as driver mutations, but the significance of truncating mutations is not clarified.
Jakob R. Passweg +2 more
exaly +6 more sources
CSF3R Mutations Imply Adverse Prognostic Impact in Adult Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study [PDF]
Background Activating colony‐stimulating factor 3 receptor (CSF3R) mutations are uncommon in acute myeloid leukemia (AML), and their prognostic significance remains unclear.
Yu Wu, Hongbing Ma, Jinjun Yang
exaly +3 more sources
Crohn’s Disease Phenotype in a Patient With Severe Congenital Neutropenia Caused by CSF3R Variants: Exploring the Pathogenesis and Effects of Thalidomide Treatment [PDF]
This study describes a case of severe congenital neutropenia (SCN) harboring biallelic CSF3R variants and presenting with a novel inflammatory bowel disease (IBD) phenotype that responded remarkably to thalidomide.
Yanqiu Wang +7 more
doaj +3 more sources
Research progress on the mechanisms of CSF3R mutations in leukemogenesis and treatment strategies [PDF]
Leukemia is a malignant clonal disease originating from hematopoietic stem cells. Its pathogenesis is associated with multiple factors, including biological, physical, chemical, genetic, and other hematological diseases.
Ningxuan Wang +3 more
doaj +5 more sources
HIF1A+CSF3R+ neutrophils-dominated hypoxic niche induced metabolic reprogramming for neoadjuvant therapy resistance in NSCLC [PDF]
Background Non-small cell lung cancer (NSCLC) is one of the frequently occurring cancers characterized by molecular heterogeneity and multiple immune cell infiltration patterns, which are associated with treatment sensitivity and resistance. However, the
Yongjie Xie +10 more
doaj +2 more sources
Integrative Transcriptomic Analysis Identifies GPX3 and CSF3R as Candidate Markers of Diabetes-Associated Myocardial Injury [PDF]
Jiayi Song,1 Yiyin Long,1 Wujing Zhang,1 Longkun Liu21Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China; 2National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan ...
Song J, Long Y, Zhang W, Liu L
doaj +2 more sources
Activating mutations in the gene encoding for receptor of colony stimulating factor 3 (CSF3R) are drivers of pathogenesis in chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML).
Matthew J Wieduwilt, Marc S Schwartz
exaly +3 more sources
Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML. [PDF]
ABSTRACT Quizartinib is a FMS‐like tyrosine kinase 3 (FLT3) inhibitor indicated for FLT3 internal tandem duplication (FLT3‐ITD)–positive acute myeloid leukemia (AML). We aimed to evaluate quizartinib resistance mechanisms, in addition to efficacy and safety outcomes, in patients with relapsed or refractory FLT3‐ITD–positive AML.
Semba Y +21 more
europepmc +2 more sources
Multiomics Integration and Machine Learning Reveal Colony Stimulating Factor 3 Receptor as a Key Gene and Therapeutic Target in Crohn’s Disease [PDF]
Crohn’s disease (CD) is a chronic inflammatory disease characterized by complex immune dysregulation in which the identification of key molecular drivers is critical for the advancement of diagnostic and therapeutic approaches.
Peihong Li +5 more
doaj +2 more sources
CSF3R mutations and variants in myeloid neoplasms: associated phenotypes, co-mutations, and survival trends [PDF]
Not available.
Abiola Bolarinwa +5 more
doaj +2 more sources

